Aratana Therapeutics

Aratana Therapeutics is a wholly owned subsidiary of @Elanco.

[Aratana Therapeutics @AratanaRx]

Today we announced Aratana stockholders adopted the merger agreement with @Elanco https://t.co/DGfixR3rQA

[KCBJ Tech & Health Care @KCBJTech_Health]

Congratulations to @AratanaRx's John Ayres on becoming a @KCBizJournal 2019 NextGen Leader.
#NextGenKC

[Aratana Therapeutics @AratanaRx]

Today we announced our 5th FDA approval! Learn more about a smaller vial size of our long-acting local anesthetic: https://t.co/zku2Y6nGCK

[Aratana Therapeutics @AratanaRx]

Today we announced voting results from our 2019 Annual Meeting of Stockholders: https://t.co/EstvRy8QHv

[Aratana Therapeutics @AratanaRx]

We reported our first quarter 2019 financial results: https://t.co/JG5FignWb9

[Aratana Therapeutics @AratanaRx]

We announced an agreement to merge with @Elanco. This integration has the potential to propel our innovation and specialty approach with a premier, global #animalhealth company: https://t.co/gXECsLjSFk

[Aratana Therapeutics @AratanaRx]

Everyday is #NationalPetDay for our furry family members!

[Aratana Therapeutics @AratanaRx]

@billblevins Please contact Elanco (1-888-545-5973) to report the adverse event. A case number has already been established - you may reference US2019_007401. If you would prefer they call you, we are happy to pass along your phone number.

[Aratana Therapeutics @AratanaRx]

We reported our fourth quarter and full year 2018 financial results and will discuss on our call today at 4:30 p.m. ET: https://t.co/AXD2eYr1cu

[Aratana Therapeutics @AratanaRx]

We plan on attending several upcoming investment conferences: https://t.co/ut66XGDqjt

[Aratana Therapeutics @AratanaRx]

We plan to host a call to report our fourth quarter and full year 2018 financial results on March 12 at 4:30 p.m. ET: https://t.co/d79ycuOBjw

[Aratana Therapeutics @AratanaRx]

Rhonda Hellums Appointed Chief Financial Officer of Aratana https://t.co/7D0dItBDha

[Aratana Therapeutics @AratanaRx]

Swing by #vmx2019 booth (975) to chat with our team about our innovative therapeutics

[Aratana Therapeutics @AratanaRx]

Calling all technicians! Join us for today’s #vmx2019 lunch session in OCCC N320 A/B to learn about managing weight loss in your CKD patients

[Aratana Therapeutics @AratanaRx]

Aratana’s Board of Directors appoints Craig Tooman as CEO of Aratana: https://t.co/XdXlQUjUm2

[Aratana Therapeutics @AratanaRx]

This holiday season our team is giving back to @rosebrookskc, a local shelter that aids families and their pets as they seek to escape immediate danger or domestic violence. Thanks to our employees for contributing!

[Aratana Therapeutics @AratanaRx]

Dr. Ernst Heinen, our Chief Development Officer, is excited to deliver how we are “Bringing Innovation to Pets and Their Veterinarians” in his presentation @NewYorkVet

[Aratana Therapeutics @AratanaRx]

We reported our third quarter 2018 financial results and will discuss on our call tomorrow morning at 8:30 a.m. ET: https://t.co/84Lf6vwmOL

[Aratana Therapeutics @AratanaRx]

We loved having our pets in the office today to show-off their “super” costumes:

[Aratana Therapeutics @AratanaRx]

We plan to host a call to report our third quarter 2018 financial results on November 2 at 8:30 a.m. ET: https://t.co/HzR5Y4otw5